HOME › DRUGS › SELUMETINIB
ACTIVE SUBSTANCE / INN

SELUMETINIB

Brand name(s): Koselugo, KOSELUGO
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
NDA219943
Neurofibromatosis 1
ACTIVE SUBSTANCE
Selumetinib
REGULATORS
FDA · EMA
SPONSORS / MAH
ASTRAZENECA, AstraZeneca AB
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
KOSELUGONDA219943ASTRAZENECAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KoselugoAstraZeneca ABAuthorised17/06/2021Neurofibromatosis 1

FULL INTELLIGENCE ON SELUMETINIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →